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Robert AJ Matthews
Department of Information Engineering, Aston University, Birmingham B4 5DT. E-mail: rajm@physics.org
Introduction
Animal models are widely recognized as being
essential to the progress of medical science. In
countering the critics’ arguments of the use of ani-
mals in medicine, one statement has acquired
almost talismanic importance:
‘Virtually every medical achievement of the last
century has depended directly or indirectly on
research with animals.’
In this essay, the origins and justification of this
oft-repeated statement are examined. Despite its
endorsement by leading academic bodies, it is far
from clear that the statement has been, or even
could be, formally validated.
Origins of the statement
The use of animal models is a long-standing and
deeply controversial aspect of medical research. In
the face of the increasing – and increasingly vocif-
erous – protest against the practice, academic insti-
tutions and individual scientists have responded
with a variety of arguments, notably a statement
summarizing the value of animal models as fol-
lows: ‘Virtually every medical achievement of the
last century has depended directly or indirectly on
research with animals’. This has been endorsed
essentially verbatim by many eminent bodies,
including the US Public Health Service, the Royal
Society, and the UK Department of Health.1–3 In
2005, over 500 eminent academics signed a public
petition supporting the statement, among them
three Nobel laureates and over 250 professors.4
It is rare for so unequivocal a statement to com-
mand such unqualified support from the scientific
community. It would not be unreasonable to
assume that this is because it is demonstrably true.
There are certainly specific instances consistent
with the statement, for example the role of animals
in the development of blood transfusions and the
identification of insulin.2 It is also undeniable that
every blockbuster drug developed in recent years
has involved the use of animal models, such
testing being mandatory in the wake of the Tha-
lidomide disaster.
However, the statement goes further than anec-
dotes taken from a few areas of medicine. It makes
two substantive claims: first, that virtually every
medical achievement of the last century has
involved animal models, and secondly that these
achievements have depended on the use of these
animals.
The claim appears to have originated in a one-
page statement by the US Public Health Service,
dated February 1994 and published in The Physiol-
ogist under the title ‘The Importance of Animals in
Biomedical and Behavioral Research’.2 It contains
no citations to the literature supporting the claim;
this is simply asserted. Subsequent reiterations of
the claim either cite this original unreferenced
source, or merely assert it in turn essentially verba-
tim (e.g. the Royal Society report states ‘.in the
past century’, rather than ‘.of the last century’).
Validating the claims
Whether, when or how the claim has ever been
validated is thus unclear. Certainly published lists
of achievements stemming from animal models
(see for example the Research Defence Society’s
Timeline5) fall far short of representing ‘virtually
all’ medical achievements of the last century.
Indeed, it is far from clear how such a claim could
ever be validated. As the well-known study by
Comroe and Dripps shows,6 identifying even basic
features of the most significant advances in a single
area of medicine is a process mired in subjectivity,
and is prone to reaching conclusions that are ‘not
repeatable, reliable, or valid’.7
Demonstrating the role of animal models in a
specific medical advance presents peculiar diffi-
culties characterized by Paton,8 and exemplified
by the fact that in his own comprehensive analysis,
he explicitly excludes any attempt to estimate the
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Demanding validation of the statement that
‘virtually all’ medical achievements of the last cen-
tury have involved animal models may seem
pedantic, but there is a point of principle here. The
eminence of many of those who have repeated this
claim, and in particular their scientific eminence,
places an obligation upon them to be able to sub-
stantiate it. The failure – and, in all likelihood,
inability – to do so exposes some of our most
respected academic institutions to a charge of
abuse of authority.
Predictive value of animal
models
Even if the first claim were capable of validation,
this would still not justify the second substantive
claim: that virtually all such achievements have
depended on animal models – that is, such models
were not merely included in the research process,
but provided demonstrable evidential weight, lead-
ing to a positive outcome. The use of animals has
long been de rigueur in medical research, and is
mandatory in drug development. As such, the
statement that virtually every medical break-
through has involved animal experiments says
nothing about the inferential value of those experi-
ments – any more than the equally ubiquitous use
of animal experiments in failed breakthroughs
proves their futility. Arguing otherwise constitutes
a well-known inferential fallacy known as transpo-
sition of the conditional (see for example Paulos9),
which in this case takes the form of wrongly
assuming the (unknown) probability of a medical
advance taking place given the use of animals is
equivalent to the (very high) probability that ani-
mals were used given a medical advance has taken
place.
To move beyond this fallacy, we can follow
Paton who urges the use of quantitative measures,
as ‘There is nothing like quantitative measurement
for sharpening the wits, calling of bluffs and set-
ting things in proportion’.8 Such an approach is
also valuable in revealing gaps in extant knowl-
edge, and providing a clear resolution of the prob-
lem of transposition of the conditional. This can be
made precise and quantitative via the familiar con-
cepts of sensitivity (i.e. the true positive rate) and
specificity (i.e. true negative rate). These lead to
various ways of quantifying evidential weight, of
which the most direct and transparent is the
so-called likelihood ratio (LR), whose definition is
such that only tests producing LR >1 can be
deemed to have contributed any weight of evi-
dence.10 More specifically the positive likelihood
ratio, LR+ in support of the hypothesis that a
specific effect will obtain, given a positive test
result, is given by the ratio
LR+ = sensitivity ⁄ (100 % −specificity)
(an analogous definition exists for negative likeli-
hood ratio, LR-, in support of the hypothesis that
a specific effect will not obtain, given a negative
test result). Thus for any putative source of evi-
dential weight to be deemed useful, its specificity
and sensitivity must be such that LR+ >1. Tossing
a coin contributes no evidential weight to a
given hypothesis as the sensitivity and specificity
are the same – 50% – and thus the LR+ is equal
to 1.
All animal models possess both sensitivity and
specificity values, and thus lead to values for the
evidential weight provided by each such model.
As such, they provide the quantitative underpin-
ning for statements about the value of animal mod-
els to medical progress. Or, rather, they would if
they existed. As has been pointed out repeatedly
by authors for several decades, there is a striking
paucity of quantitative comparative data for ani-
mal models.11–13
Various explanations for this can be offered.
First and most obviously, compounds that pro-
duce unacceptable effects in animal models will
not progress to human trials, making studies capa-
ble of giving sensitivity/false positive rates for
animal models ethically problematic. Secondly, it
is frequently difficult to establish end-points suffi-
ciently clear-cut to allow categorization as true
positives or true negatives. Thirdly, much of the
comparative animal-human data is obtained
under conditions of commercial confidentiality.
These are all serious difficulties for those seeking
to show that the value of animal models is sup-
ported by quantitative evidence rather than anec-
dote.14
Published evidence of predictive
value
None of these difficulties is, however, insuper-
able. While there may be relatively few quantitat-
ive studies of the predictive abilities of animal
models, they do exist. The principal source of
such studies is in an area where both critics and
advocates agree there is a pressing need for the
validation of animal models: toxicity testing.15
Despite the difficulties, several authors have
succeeded in acquiring comparative data from
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animal and human studies with a view to estimat-
ing the evidential weight provided by the animal
models in relation to specific organ toxicities. Re-
grettably, the data provided by these studies is
typically incomplete, ambiguous, and subjected
to inadequate or incorrect analysis. As a result,
the estimates for the evidential weight of animal
models that emerge are at best inconclusive, and
sometimes wholly misleading.
For example, the largest review of the predic-
tive performance of animal toxicity studies covers
150 drugs specifically associated with adverse
events or toxicity in humans in testing by phar-
maceutical companies.16 Using unpublished data,
it found a figure for the sensitivity for rodent and
non-rodent species collectively of 71%. However,
as its authors make clear, the review did not at-
tempt to estimate the corresponding specificity,
stating that ‘a more complete evaluation of this
predictivity aspect will be an important part of a
future prospective survey’. Yet without this, it is
simply impossible to assess the evidential weight
provided by the animal models.
In his review of the predictive power of seven
animal models for toxic lesions in humans,17
Hottendorf provides explicit values for both the
false positive and false negative rates. Unfortu-
nately, these are based on incorrect definitions,
while other data are stated in a format that
precludes calculation of unambiguous values for
the LRs (see Appendix). Despite these short-
comings, it is certainly possible to agree with Hot-
tendorf’s conclusion that ‘The predictive value of
toxicological studies performed in animal species
and the incidence of species differences in
toxicity could and should be placed in sharper per-
spective with an expanded data base’ (emphasis
added).
The review of comparative anticancer drug tox-
icity by Schein et al.11 is exceptional in providing
sufficient data to allow direct calculation of sensi-
tivity, specificity and LRs provided by the animal
models studied. Once again, however, the values
quoted by the authors cannot be used directly, as
they are based on incorrect definitions (regretta-
bly, this has not prevented the values being cited
directly by other authors13). When calculated
correctly (see Appendix), the LRs of the animal
models examined by Schein et al.11 have 95%
confidence intervals that fail to exclude unity for
all ten of the organ system toxicities considered. In
other words, the data provide no statistically cred-
ible evidence that these animal models contribute
any predictive value, either separately or in
combination.
So do animal models have
predictive value?
The debate over the use of animals in medical
experiments has a long and often bitter history.
Researchers and those associated with them can
now find themselves targeted by verbally if not
physically abusive ‘activists’. It is therefore per-
haps not surprising that the research community
has responded by becoming more assertive in its
claims. In 1990, many eminent researchers, includ-
ing six Nobel Prize winners, signed a declaration
prepared by the Research Defence Society that
made the wholly unexceptionable claim that
experiments on animals have made ‘an important
contribution’ to advances in medicine and surgery.
By 2005, with intimidation against those involved
in animal experiments regularly making head-
lines, the declaration had been extended to include
the statement discussed in this essay: that ‘virtu-
ally every medical achievement in the past cen-
tury’ has relied on animal models in some way.
As we have seen, despite its now routine use by
the scientific community, it is far from clear that
this statement has been, or even could be, formally
validated. This is not to say that animal models do
not provide evidential weight, still less that they
have no role in research. There are many examples
of research on animals providing insights that
have transformed medical science. Regrettable as
it might be, however, it is not possible to go
beyond these anecdotal examples to the altogether
more impressive statement now being promoted
by various prestigious academic bodies and
individuals.
The scientific community can choose to deal
with the current situation in one of three ways. The
simplest is to replace the current statement with
one which can be formally validated. This need not
be a vapid platitude: there is a wealth of evidence
to support a statement such as ‘Animal models can
and have provided many crucial insights that have
led to major advances in medicine and surgery’.
The second and most valuable course of action
would be to embark on a systematic study of the
use of animal models with a view to establishing
the weight of evidence they provide. This would
undoubtedly be a major undertaking, but it would
also bring many benefits – not the least of which
would be quantitative support for the claims made
for animal models.
The third option is simply to turn a blind eye to
the continued promulgation of a statement about
the importance of animal experiments lacking in
logical or evidential support.
Medical progress depends on animal models – doesn’t it?
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Appendix: Calculation of evidential weight provided by animal models
To assess the evidential weight of an animal model, we require data from a comparative study capable of
giving values for the sensitivity and specificity of the model. Schein et al. provides such data in the
specific case of organ toxicity for anticancer drugs; however, their values for the sensitivity and
specificity are based on incorrect definitions, and so cannot be used to calculate evidential weight as
reflected in the Likelihood Ratio (LR), where LR = sensitivity / (100% – specificity). Similar problems
affect the values quoted by Hottendorf.
To illustrate the consequences, the following contingency table contains comparative data taken from
Schein et al. for cases of injection site toxicity as observed in monkeys and humans.
Toxicity observed in human Toxicity not observed in human Total
Toxicity observed in animal 3 6 9
Toxicity not observed in
animal
2 12 14
Totals 5 18 23
Based on this data, we then calculate the various measures of evidential weight according to the
definitions adopted by Schein et al. and Hottendorf, and compare them to the values obtained using the
correct definition.
Quantity Schein et al. Hottendorf Actual
True positive rate (Sensitivity) 13% Not calculable 60%
True negative rate
(Specificity)
52% Not calculable 67%
False positive rate 26% 26% 33%
False negative rate 9% 9% 40%
LR (95% CI) 0.27 Not calculable 1.8 (0.6, 3.4)
The final row shows that the LR value calculated using Schein et al.’s definitions is incorrect, the value
from Hottendorf’s definition is not calculable, while the correct LR fails to exclude 1.0 at the 95%
confidence level, and thus fails to supply evidence that the animal model has any evidential value.
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